Pharmacoeconomic study of fluorescent lymphography and radionuclide diagnostics methods for sentinel lymph node detection in breast cancer

Background. Sentinel lymph node (SLN) biopsy is a reliable diagnostic method used to assess the spread of the malignant process in regional lymph nodes. Currently, this method is of great importance in treatment planning for early breast cancer and allows to avoid immediate and long-term complications of lymph node dissection. SLN detection can be performed using the radionuclide method, the disadvantages of which are associated with the peculiarities of working with radiopharmaceuticals and additional costs when using them. An alternative method is fluorescence lymphography (FL) with indocyanine green.
Objective: performing a pharmacoeconomical study (cost-effectiveness analysis) comparing the cost-effectiveness of methods for detecting SLN in breast cancer: radionuclide diagnosis (RD) using a radiopharmaceutical based on sodium pertechnetate [^99mТс] and FL using indocyanine green (Life Sciences OCPK LLC, Russia) and "IC GOR System" device (Central Design Bureau of Information and Control Systems JSC, Russia).
Material and methods. The values of the cost-effectiveness ratio (CER) were calculated and compared for the two indicated methods of detecting SLN in breast cancer. Information on the RD method clinical efficacy was taken from the published data. SLN detection by the FL method with the use of indocyanine green and domestic apparatus was performed on the basis of the Regional Clinical Oncology Dispensary (Ryazan) in 53 patients with breast cancer. To assess the reliability of the obtained results a deterministic multivariate sensitivity analysis was performed.
Results. The obtained CER_FL values were significantly lower than the median CER_RD values by average of 43.29% (p<0.001): from 40.36% (p<0.001) to 44.96% (p<0.001). The geometric mean CER_FL was lower than CER_RD by 39,40% (from 37.99% to 42.80%), and their 95% confidence intervals (CI) did not intersect. Deterministic multivariate sensitivity analysis demonstrated robustness of the obtained data to the transformation of RD cost parameters. Nevertheless the geometric mean and its 95% CI of CER_RD and CER_FL did not intersect under any circumstances.
Conclusion. According to the results of a pharmacoeconomic study, it is more economically profitable to detect SLN in breast cancer using indocyanine green and a domestic device for FL, as its costs per unit of efficiency were 38–45% lower than for RD using a radiopharmaceutical based on sodium pertechnetate [^99mТс].

1. Mordvinov A.A., Pivovarov D.V., Pivovarova A.R. Ethical and deontological issues of informing in oncological practice. Nauka molodukh (Eruditio Juvenium). 2021; 9 (2): 335–41 (in Russ.). https://doi.org/10.23888/HMJ202192335-3.

2. Clinical guidelines “Breast cancer”. 2021. Available at: https://cr.minzdrav.gov.ru/schema/379_4 (in Russ.) (accessed 25.08.2023).

3. Malashenko V.N., Ershova Yu.V., Ershov A.M. Computer model for identification of groups of risk for malignant neoplasms of female sex sphere using questionnaire. I.P. Pavlov Russian Medical Biological Herald. 2019; 27 (2): 219–26 (in Russ.). https://doi.org/10.23888/PAVLOVJ 2019272219-226.

4. Kaprin A.D., Starinskiy V.V., Shakhzadova A.O. (Eds.) Malignant neoplasms in Russia in 2022. Мoscow: Herzen Moscow Research Oncological Institute – branch of National Medical Research Center of Radiology; 2023: 254 pp. (in Russ.).

5. Zikiryakhodzhaev A.D., Starkova M.V., Timoshkin V.O. Indocyanine green in diagnostics and reconstructive surgery for breast cancer. Pirogov Russian Journal of Surgery. 2023; 9-2: 20–4 (in Russ.). https://doi.org/10.17116/hirurgia202309220.

6. Labushkina A.A., Klement’eva O.E., Kodina G.E., et al. Clinical study of the drug “Nanotech, 99mTc” for the detection of sentinel lymph nodes in patients with breast cancer. Medical Radiology and Radiation Safety. 2022; 67 (3): 75–82 (in Russ.). https://doi.org/10.33266/1024-6177-2022-67-3-75-82.

7. Unified information system in the field of procurement. Available at: https://zakupki.gov.ru/epz/main/public/home.html (in Russ.) (accessed 25.08.2023).

8. Instructions for the medical use of the drug “Nanotech, 99mTc”. Available at: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=509b7e9b-3d0f-436d-a0c9-586e19bb3bf7 (in Russ.) (accessed 25.08.2023).

9. Yagudina R.I., Zinchuk I.Yu. Pharmacoeconomic study of skin tests in the diagnostics of tuberculosis infection. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2013; 6 (1): 11–5 (in Russ.).

10. Yagudina R.I., Kulikov A.Yu., Metelkin I.A. Methodology of costeffectiveness analysis in pharmacoeconomics. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2012; 5 (4): 3–8 (in Russ.).

11. Kalinin R.E., Suchkov I.A., Uporov M.M., et al. Pharmacoeconomic study of various treatment options for superficial vein thrombophlebitis of lower extremities. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2023; 16 (2): 210–20 (in Russ.). https://doi.org/10.17749/2070-4909/farmakoekonomika.2023.172.